Medicare Coverage for Weight Loss Injections
Medicare Part D and Medicare Advantage plans may cover some weight loss injections when prescribed for a covered condition like obesity or type 2 diabetes. Original Medicare (Parts A and B) generally does not cover drugs for weight loss, but Part D and Advantage plans can include injectable medications such as semaglutide and tirzepatide when deemed medically necessary. Coverage depends on the specific plan formulary, the prescribing doctor's diagnosis, and whether the drug is on the plan's preferred list. You can check your plan's formulary or contact your plan directly to confirm coverage for a specific injection on Medicare.gov.
Medicare covers injectable obesity drugs only when they are prescribed to treat obesity or a related condition and the drug is FDA-approved for weight management. As of the latest public updates, Medicare Part D and Medicare Advantage plans can include drugs like Wegovy (semaglutide) and Mounjaro (tirzepatide) if the plan's formulary lists them and the prescriber documents medical necessity. Medicare Advantage plans must cover at least the same benefits as Original Medicare but can set their own rules for prior authorization, step therapy, and quantity limits. Beneficiaries should verify coverage with their plan and ask their doctor to submit documentation supporting the medical need for the injection.
Eligibility and Requirements for Medicare Weight Loss Injection Coverage
To qualify for Medicare coverage of weight loss injections, you must have a diagnosis of obesity or a related condition such as type 2 diabetes, hypertension, or obstructive sleep apnea. Your doctor must document that the injection is medically necessary and that other weight loss methods, such as diet and exercise, have been tried or are not appropriate. Medicare Part D and Medicare Advantage plans may require prior authorization, meaning your doctor must submit clinical information before the plan approves coverage. Plans can also apply step therapy, requiring you to try and fail on a preferred, lower-cost medication before covering a brand-name injectable.
Common Medical Criteria for Coverage
Medicare plans typically require a body mass index (BMI) of 30 or higher for obesity coverage, or a BMI of 27 or higher with at least one weight-related comorbidity. The prescribing provider must be a Medicare-enrolled doctor or qualified healthcare professional. Coverage is usually limited to FDA-approved drugs for chronic weight management, and plans may restrict coverage to specific formulations or require the use of a preferred pharmacy network. Some plans also require regular follow-up visits and progress documentation to continue coverage beyond the initial prescription period.
Costs, Copays, and Out-of-Pocket Expenses
Costs for weight loss injections under Medicare vary by plan, drug, and pharmacy. Part D plans charge a monthly premium, annual deductible, and copay or coinsurance for covered drugs. Medicare Advantage plans may have lower or higher out-of-pocket costs depending on the plan's tier structure and pharmacy network. Brand-name injectables like Wegovy and Mounjaro can have higher copays, but some plans offer preferred pricing or manufacturer savings programs that lower the cost. Beneficiaries should check their plan's drug list and cost-sharing details before starting treatment to understand their expected out-of-pocket expenses.
Tips to Reduce Costs
You can lower costs by using a preferred pharmacy within your plan's network, asking your doctor for a generic alternative if available, and checking for manufacturer copay cards or patient assistance programs. Some Medicare Advantage plans include additional benefits like gym memberships or telehealth weight management programs that can complement injectable treatment. If a plan does not cover a specific injection, your doctor can request a formulary exception or help you switch to a covered alternative. Always confirm coverage and costs directly with your plan before filling a prescription to avoid unexpected bills.